Compare GRFS & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | ENPH |
|---|---|---|
| Founded | 1940 | 2006 |
| Country | Spain | United States |
| Employees | 23800 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.8B |
| IPO Year | N/A | 2011 |
| Metric | GRFS | ENPH |
|---|---|---|
| Price | $8.93 | $45.79 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 25 |
| Target Price | $10.15 | ★ $43.48 |
| AVG Volume (30 Days) | 446.1K | ★ 7.9M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ 72.00 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $1,472,985,000.00 |
| Revenue This Year | $5.47 | N/A |
| Revenue Next Year | $4.92 | $9.78 |
| P/E Ratio | ★ $18.67 | $37.59 |
| Revenue Growth | N/A | ★ 10.72 |
| 52 Week Low | $6.19 | $25.78 |
| 52 Week High | $11.14 | $66.70 |
| Indicator | GRFS | ENPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 53.77 |
| Support Level | $8.66 | $34.38 |
| Resistance Level | $9.11 | $53.68 |
| Average True Range (ATR) | 0.29 | 3.13 |
| MACD | -0.05 | -0.29 |
| Stochastic Oscillator | 42.28 | 29.44 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.